Showing results (581-590 of 3,079) with videos related to

Sort By:
Pageof 308
Drug Safety|July 17, 2021
Is There an Increased Risk of Hepatotoxicity with Metamizole? A Comparative Cohort Study in Incident UsersKarin Hedenmalm, Alexandra Pacurariu, Jim Slattery, et al.
Drug Safety|June 6, 2021
Capturing Data in Rare Disease Registries to Support Regulatory Decision Making: A Survey Study Among Industry and Other StakeholdersCarla J Jonker, Sieta T de Vries, H Marijke van den Berg, et al.
Drug Safety|March 9, 2020
Fluoroquinolone-Induced Photosensitivity: A Chemical Fragment-Based Approach by a Case/Non-case Study in VigiBase®Yoann Zelmat, Vanessa Rousseau, Leila Chebane, et al.
Drug Safety|February 2, 2020
An Integrated Analysis of the Safety of Tofacitinib in Psoriatic Arthritis across Phase III and Long-Term Extension Studies with Comparison to Real-World Observational DataGerd R Burmester, Jeffrey R Curtis, Huifeng Yun, et al.
Drug Safety|January 26, 2020
Hyperkeratotic Skin Adverse Events Induced by Anticancer Treatments: A Comprehensive ReviewMaria Vastarella, Gabriella Fabbrocini, Vincent Sibaud
Drug Safety|March 14, 2020
Patterns of Inpatient Antibiotic Use Among Public Hospitals in Hong Kong from 2000 to 2015Celine S L Chui, Benjamin J Cowling, Wey Wen Lim, et al.
Drug Safety|August 29, 2020
Current Evidence on Abuse and Misuse of GabapentinoidsStaffan Hägg, Anna K Jönsson, Johan Ahlner
Drug Safety|August 31, 2020
Post-Marketing Safety Surveillance for the Adjuvanted Recombinant Zoster Vaccine: MethodologyFernanda Tavares-Da-Silva, Olivia Mahaux, Lionel Van Holle, et al.
Drug Safety|October 1, 2020
Introduction or Discontinuation of Additional Risk Minimisation Measures During the Life Cycle of Medicines in EuropeReynold D C Francisca, Emna Baba, Christina E Hoeve, et al.
Drug Safety|December 23, 2020
Developing Crowdsourced Training Data Sets for Pharmacovigilance Intelligent AutomationAlex Gartland, Andrew Bate, Jeffery L Painter, et al.
Pageof 308